ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
March 2026
Nuclear Technology
February 2026
Fusion Science and Technology
January 2026
Latest News
Mirion announces appointments
Mirion Technologies has announced three senior leadership appointments designed to support its global nuclear and medical businesses while advancing a company-wide digital and AI strategy. The leadership changes come as Mirion seeks to advance innovation and maintain strong performance in nuclear energy, radiation safety, and medical applications.
Yu-Keung Sze, Joseph Alfred Gosselin
Nuclear Technology | Volume 63 | Number 3 | December 1983 | Pages 431-441
Technical Paper | Chemical Processing | doi.org/10.13182/NT83-A33270
Articles are hosted by Taylor and Francis Online.
A systematic method has been used to screen a number of potential stabilizers (holding reductants) for Pu(III) in tri-n-butyl phosphate/diluent solutions used in irradiated fuel reprocessing systems. The conditions assumed were similar to those used in solvent extraction contactor operations. Of the reagents tested, oximes as a group appeared to be very effective. Acetaldoxime, in particular, was selected for extensive tests and was used as a Pu(III) stabilizer, in both the aqueous and organic phases, in contactor runs for plutonium partition from thorium and uranium. In the best results, the plutonium loss to the thorium/uranium stream was 2.8 × 10−5 g/ℓ or 0.0046%; without using acetaldoxime, the loss was 12%. Rates of plutonium reduction in 1.5 M nitric acid have been compared for a number of reducing agents under identical conditions. Some derivatives of hydroxylamine were found to be much more effective than hydroxylamine itself.